Fund . AMEX . SPDR . USD
State Street SPDR S&P Biotech ETF
State Street SPDR S&P Biotech ETF is a fund listed on AMEX. It holds securities and files no accounts of its own, so the figures below are what it holds, what it costs and how concentrated it is. Its largest sector is Healthcare.
Market data, for 2026-11-06. Written to our own tables on 2026-10-15.
We do not hold the index this fund tracks, so its drift is not measured. It is measurable, and it is not measured yet.
What it holds
- MODERNA INC2.6%
- NATERA INC1.8%
- TWIST BIOSCIENCE CORP1.8%
- ABBVIE INC1.7%
- BIOGEN INC1.7%
- AMGEN INC1.7%
- HALOZYME THERAPEUTICS INC1.7%
- IOVANCE BIOTHERAPEUTICS INC1.7%
- UNITED THERAPEUTICS CORP1.6%
- GILEAD SCIENCES INC1.6%
- EXELIXIS INC1.6%
- TG THERAPEUTICS INC1.5%
- REGENERON PHARMACEUTICALS1.5%
- VERTEX PHARMACEUTICALS INC1.5%
- KRYSTAL BIOTECH INC1.5%
- PROTAGONIST THERAPEUTICS INC1.4%
- REVOLUTION MEDICINES INC1.4%
- GRAIL INC1.4%
- CRISPR THERAPEUTICS AG1.4%
- VAXCYTE INC1.4%
- SPYRE THERAPEUTICS INC1.4%
- INCYTE CORP1.4%
- PTC THERAPEUTICS INC1.4%
- NEUROCRINE BIOSCIENCES INC1.4%
- ALNYLAM PHARMACEUTICALS INC1.3%
the largest 25 of 165 lines it discloses, as the fund disclosed them on 2026-10-15.
What a fund cannot have
A fund files no accounts of its own.
Earnings per share
A fund has no accounts of its own. What it holds earns, reports and owns; the wrapper around them does not, so this figure has nothing to be measured from.
Return on equity
A fund has no accounts of its own. What it holds earns, reports and owns; the wrapper around them does not, so this figure has nothing to be measured from.
Revenue
A fund has no accounts of its own. What it holds earns, reports and owns; the wrapper around them does not, so this figure has nothing to be measured from.
Book value per share
A fund has no accounts of its own. What it holds earns, reports and owns; the wrapper around them does not, so this figure has nothing to be measured from.
US ETFs with a page: 990, counted 2026-11-08